Table 1.

Baseline characteristics of participants

Age, years, median (Q1; Q3)75.0 (69.0; 81.0)
Age, years, n/N
  Sex, female, n/N1522/357442.6
  Ethnicity, White, n/N3441/348398.8
  Body mass index, median (Q1; Q3)28.1 (25.0; 32.3)
Medical history, n/N
  Congestive heart failure274/35737.7
  Coronary artery disease678/357319.0
  Acute coronary syndromes363/356110.2
  Carotid occlusive disease52/35151.5
  Prior stroke/TIA/systemic embolism450/355112.7
  Vascular diseasea760/355121.4
  History of bleeding109/35603.1
  Diabetes mellitus629/357317.6
  Chronic kidney disease (grade ≥3)896/349925.6
CHA2DS2-VASc, median (Q1; Q3)3.0 (2.0; 4.0)
CHA2DS2-VASc score categories, n/N
HAS-BLED score, median (Q1; Q3)b2.0 (1.0; 2.0)
HAS-BLED score categories, n/N b
Care setting at diagnosis, n/N
  Internal medicine779/357321.8
  Primary care/general practice2183/357361.1
  • a Defined as peripheral artery disease and/or coronary artery disease.

  • b The risk factor ‘Labile INRs’ is not included in the HAS-BLED score as these data are not collected at baseline. As a result, the maximum HAS-BLED score at baseline is eight points (not nine). INR = international normalisation ratio. Q1 = quartile 1. Q3 = quartile 3. TIA = transient ischaemic attack.